netFormulary
 Report : A-Z CDF items in Formulary 23/10/2017 23:39:33
[Back]
 
Section Status CDF Name
08.01.01 Formulary Cancer Drugs Fund Bendamustine 
08.01.05 Formulary Cancer Drugs Fund Bevacizumab Avastin
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade
08.01.05 Formulary Cancer Drugs Fund Bosutinib  Bosulif
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris
08.01.05 Restricted Use Cancer Drugs Fund Cabazitaxel 
08.01.05 Restricted Use Cancer Drugs Fund Cetuximab Erbitux
08.01.05 Formulary Cancer Drugs Fund Crizotinib  Xalkori
08.01.05 Formulary Cancer Drugs Fund Dabrafenib  Tafinlar
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel
08.01.05 Formulary Cancer Drugs Fund Enzalutamide Xtandi
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven Solution for Injection
08.01.05 Restricted Use Cancer Drugs Fund Everolimus Afinitor
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy
08.02.04 Formulary Cancer Drugs Fund Lenalidomide 
08.01.05 Restricted Use Cancer Drugs Fund Nivolumab  Opdivo
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza
08.01.05 Restricted Use Cancer Drugs Fund Osimertinib  TAGRISSO
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak
08.01.02 Formulary Cancer Drugs Fund Pegylated Liposomal Doxorubicin Hydrochloride 
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda
08.01.03 Formulary Cancer Drugs Fund Pemetrexed Alimta
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta Concentrate for Solution for Infusion
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib Jakavi
08.01.05 Restricted Use Cancer Drugs Fund Sunitinib Sutent
08.02.04 Restricted Use Cancer Drugs Fund Talimogene  Imlygic
08.01.05 Restricted Use Cancer Drugs Fund Trametinib  Mekinist
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine Kadcyla
Berkshire West NHS